RecruitingNCT05482269

Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography

Prediction of Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography


Sponsor

Shengjing Hospital

Enrollment

2,000 participants

Start Date

Jan 1, 2011

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators aim to build a predictive tool for Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • age of ≥ 18 years and a pulmonary embolism diagnosis based on CT pulmonary angiography

Exclusion Criteria3

  • pregnancy
  • reception of reperfusion treatment before admission
  • missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERno intervention

no intervention


Locations(1)

Shengjing Hospital

Shenyang, Liaoning, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05482269


Related Trials